Comments
Roche melanoma drug wins European green light
16.12.2011. | LONDON (Reuters) - European regulators have recommended approval of a targeted melanoma drug from Swiss group Roche Holding AG, opening the way to a new treatment option for patients with the deadliest form of skin cancer....
